Business
Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System
Accuray Incorporated (NASDAQ: ARAY) announced today that 5D Clinics has treated the first patients in the city of Melbourne, Australia, using the CyberKnife S7™ System. 5D Clinics and joint venture partner Icon Group will open and operate CyberKnife System centers across Australia*, with the goal of making it easier for cancer patients to obtain state-of-the-art precision robotic stereotactic body radiation therapy (SBRT) and stereotactic radio surgery (SRS) treatments closer to home. With an in
About this update from Icon Group Ltd
5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Radiation Treatments for More Communities Across Australia. MADISON, Wis., Oct. 8, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that 5D Clinics has treated the first patients in the city of Melbourne, Australia, using the CyberKnife S7™ System. 5D Clinics and joint venture partner Icon Group will open and operate CyberKnife System centers across Australia*, with the goal of making it easier for cancer patients to obtain state-of-the-art precision robotic stereotactic body radiation therapy (SBRT) and stereotactic radio surgery (SRS) treatments closer to home. With an initial focus on the East Coast of Australia, the new center in Melbourne is the first to be managed by the JV. "We couldn't be prouder to announce the first CyberKnife System patient treatments resulting from our partnership with the 5D Clinics and Icon Group joint venture. We have a shared vision and commitment to advancing cancer care globally and the opening of the center in Melbourne is a first step―and important reminder―of the power of determination in bringing that vision to life," said Suzanne Winter, president and CEO of Accuray. "The CyberKnife System fills an unmet need in Australia to improve community access to this powerful technology that offers both personalized and precise cancer care treatments. We look forward to continuing to work together with 5D Clinics, Icon Group and our long-term distributor partner alphaXRT, to transform cancer management in the region." The number of new cancer cases diagnosed in Australia is projected to grow from 212,332 in 2022 to 318,285 in 20451, a nearly 50 percent increase1. The rise in patient diagnoses reinforces the need for innovative new treatment options, such as the CyberKnife System, that can effectively manage the disease while improving the care journey and its impact on patients' quality of life. One of the first patients treated was David, a 55-year old diagnosed with prostate cancer. "Choosing the CyberKnife System gave me such relief knowing I didn't have to face surgery or long hospital stays," David said. "It's allowed me to keep working and get on with life without the downtime of traditional procedures. The result...